Fetal activity determination and neosynephrine test for evaluation of fetal well-being in high risk pregnancies.
At the special outpatient clinic for high risk pregnancies, a total of 197 patients were evaluated with fetal activity acceleration determination (FAD) as a non stress test. FAD was done on 197 patients, of these there were 8 fetal distress (4.7%) and 3 low Apgar scores (1 minute Apgar score less than 6) (1.8%) of 169 positive FAD, on the other hand, 14 fetal distress (50%) and 10 low Apgar scores (35.7%) of 28 negative FAD. Neosynephrine Test was performed in 62 cases as a stress test and the correlation between these two tests was evaluated. In 51 instances FAD was positive and the simultaneous Neosynephrine Test was normal. In 2 cases of negative FAD with positive Neosynephrine Test, there were 2 fetal distress (100%) and 2 low Apgar scores (100%). All the two tests are reliable for fetal evaluation in high risk pregnancies, because FAD and Neosynephrine Test are less time consuming and have fewer contraindications. It is concluded that the combination of these two tests are the most useful screening methods for fetal evaluation in high risk pregnancies.
D005069:Evaluation Studies as Topic; D005260:Female; D005318:Fetal Heart / Q000502:physiology; D005323:Fetal Monitoring / Q000379:methods*; D006339:Heart Rate; D006801:Humans; D010656:Phenylephrine; D011247:Pregnancy; D011248:Pregnancy Complications; D012306:Risk
D010656:Phenylephrine